Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study
BackgroundPrimary hyperparathyroidism (PHPT) is a condition recognized to include distinct biochemical phenotypes: hypercalcemic, normocalcemic, and normohormonal PHPT. This condition is characterized by inappropriately elevated parathyroid hormone (PTH) levels relative to serum calcium levels, lead...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1562340/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849718841159974912 |
|---|---|
| author | Margot Giocondo Belén Ponte Sophie de Seigneux Samira M. Sadowski Benoît Bédat Frédéric Triponez Marco Stefano Demarchi |
| author_facet | Margot Giocondo Belén Ponte Sophie de Seigneux Samira M. Sadowski Benoît Bédat Frédéric Triponez Marco Stefano Demarchi |
| author_sort | Margot Giocondo |
| collection | DOAJ |
| description | BackgroundPrimary hyperparathyroidism (PHPT) is a condition recognized to include distinct biochemical phenotypes: hypercalcemic, normocalcemic, and normohormonal PHPT. This condition is characterized by inappropriately elevated parathyroid hormone (PTH) levels relative to serum calcium levels, leading to high bone turnover and decreased bone mineral density (BMD). Although BMD has been shown to improve following curative parathyroidectomy (PTX), there is limited data on the relationship between BMD changes after PTX and according to the clinical phenotypes of PHPT. This prospective study aims to identify the best candidates for surgery among these three phenotypes of PHPT by examining symptoms and comorbidities, biochemical results, and both pre- and post-operative DXA scans.MethodsThis is a prospective single-center study including 104 consecutive patients who underwent PTX for PHPT. Sociodemographic profiles and biochemical results were collected at both pre- and at 6 months post-surgery. All patients underwent dual-energy x-ray absorptiometry (DXA) scans at 1 and 6 months before surgery, and again between 12 and 18 months after surgery, to assess and compare changes in bone mineral density (BMD). Patients were categorized into three subgroups (normohormonal, hyperparathyroid normocalcemic and hyperparathyroid hypercalcemic) to assess differences in BMD improvement across these groups.ResultsAccording to predefined thresholds, 40.0% of patients experienced a significant BMD gain at the spine, 35.1% at the femur, 23.5% at the left hip, and 8.6% at the radius. Additionally, a greater postoperative drop in PTH was associated with larger BMD gains at the spine (SD 0.07; mean 0.03) and left femur bone (SD 0.06; mean 0.02). There was no significant change in T-score at the one-third radius. Higher preoperative urinary calcium level was associated with greater BMD and T-score improvement at the left hip. All PHPT phenotypes demonstrated similar postoperative BMD gains. No differences in BMD improvement were observed between males and females, nor was there any correlation between BMD gains and age.ConclusionsOur findings suggest that BMD improves in all PHPT patients undergoing curative PTX, irrespective of clinical phenotype, age or sex. While patients with more severe biochemical profiles exhibited greater increases in BMD and T-scores, milder forms showed favorable trends that require confirmation in larger studies. |
| format | Article |
| id | doaj-art-f4e012207bd648d6829b9a44b4e2bc5b |
| institution | DOAJ |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-f4e012207bd648d6829b9a44b4e2bc5b2025-08-20T03:12:16ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-05-011610.3389/fendo.2025.15623401562340Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective studyMargot Giocondo0Belén Ponte1Sophie de Seigneux2Samira M. Sadowski3Benoît Bédat4Frédéric Triponez5Marco Stefano Demarchi6Department of Thoracic and Endocrine Surgery and Faculty of Medicine, University Hospitals of Geneva, Geneva, SwitzerlandNephrology and Hypertension Division, Department of Medicine, University Hospitals of Geneva, Geneva, SwitzerlandNephrology and Hypertension Division, Department of Medicine, University Hospitals of Geneva, Geneva, SwitzerlandNeuroendocrine Cancer Therapy Section, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United StatesDepartment of Thoracic and Endocrine Surgery and Faculty of Medicine, University Hospitals of Geneva, Geneva, SwitzerlandDepartment of Thoracic and Endocrine Surgery and Faculty of Medicine, University Hospitals of Geneva, Geneva, SwitzerlandDepartment of Thoracic and Endocrine Surgery and Faculty of Medicine, University Hospitals of Geneva, Geneva, SwitzerlandBackgroundPrimary hyperparathyroidism (PHPT) is a condition recognized to include distinct biochemical phenotypes: hypercalcemic, normocalcemic, and normohormonal PHPT. This condition is characterized by inappropriately elevated parathyroid hormone (PTH) levels relative to serum calcium levels, leading to high bone turnover and decreased bone mineral density (BMD). Although BMD has been shown to improve following curative parathyroidectomy (PTX), there is limited data on the relationship between BMD changes after PTX and according to the clinical phenotypes of PHPT. This prospective study aims to identify the best candidates for surgery among these three phenotypes of PHPT by examining symptoms and comorbidities, biochemical results, and both pre- and post-operative DXA scans.MethodsThis is a prospective single-center study including 104 consecutive patients who underwent PTX for PHPT. Sociodemographic profiles and biochemical results were collected at both pre- and at 6 months post-surgery. All patients underwent dual-energy x-ray absorptiometry (DXA) scans at 1 and 6 months before surgery, and again between 12 and 18 months after surgery, to assess and compare changes in bone mineral density (BMD). Patients were categorized into three subgroups (normohormonal, hyperparathyroid normocalcemic and hyperparathyroid hypercalcemic) to assess differences in BMD improvement across these groups.ResultsAccording to predefined thresholds, 40.0% of patients experienced a significant BMD gain at the spine, 35.1% at the femur, 23.5% at the left hip, and 8.6% at the radius. Additionally, a greater postoperative drop in PTH was associated with larger BMD gains at the spine (SD 0.07; mean 0.03) and left femur bone (SD 0.06; mean 0.02). There was no significant change in T-score at the one-third radius. Higher preoperative urinary calcium level was associated with greater BMD and T-score improvement at the left hip. All PHPT phenotypes demonstrated similar postoperative BMD gains. No differences in BMD improvement were observed between males and females, nor was there any correlation between BMD gains and age.ConclusionsOur findings suggest that BMD improves in all PHPT patients undergoing curative PTX, irrespective of clinical phenotype, age or sex. While patients with more severe biochemical profiles exhibited greater increases in BMD and T-scores, milder forms showed favorable trends that require confirmation in larger studies.https://www.frontiersin.org/articles/10.3389/fendo.2025.1562340/fullprimary hyperparathyroidismbone mineral densityparathyroidectomydual-energy x-ray absorptiometrynormocalcemic hyperparathyroidism |
| spellingShingle | Margot Giocondo Belén Ponte Sophie de Seigneux Samira M. Sadowski Benoît Bédat Frédéric Triponez Marco Stefano Demarchi Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study Frontiers in Endocrinology primary hyperparathyroidism bone mineral density parathyroidectomy dual-energy x-ray absorptiometry normocalcemic hyperparathyroidism |
| title | Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study |
| title_full | Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study |
| title_fullStr | Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study |
| title_full_unstemmed | Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study |
| title_short | Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study |
| title_sort | factors influencing bone mineral density in hyperparathyroidism phenotypes a prospective study |
| topic | primary hyperparathyroidism bone mineral density parathyroidectomy dual-energy x-ray absorptiometry normocalcemic hyperparathyroidism |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2025.1562340/full |
| work_keys_str_mv | AT margotgiocondo factorsinfluencingbonemineraldensityinhyperparathyroidismphenotypesaprospectivestudy AT belenponte factorsinfluencingbonemineraldensityinhyperparathyroidismphenotypesaprospectivestudy AT sophiedeseigneux factorsinfluencingbonemineraldensityinhyperparathyroidismphenotypesaprospectivestudy AT samiramsadowski factorsinfluencingbonemineraldensityinhyperparathyroidismphenotypesaprospectivestudy AT benoitbedat factorsinfluencingbonemineraldensityinhyperparathyroidismphenotypesaprospectivestudy AT frederictriponez factorsinfluencingbonemineraldensityinhyperparathyroidismphenotypesaprospectivestudy AT marcostefanodemarchi factorsinfluencingbonemineraldensityinhyperparathyroidismphenotypesaprospectivestudy |